Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Wilcox

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Future Microbiology|August 6, 2016
Interview with Professor Mark WilcoxMark Wilcox
Annals of Internal Medicine|February 21, 2018
Increasing Incidence of Multiply Recurrent Clostridium difficile InfectionMark Wilcox
BMJ (Clinical Research Ed.)|February 14, 2013
Assuring the quality of diagnostic tests: how do we know that they do what we think they do?Mark Wilcox
Journal of Clinical Pathology|December 2, 2010
Reference assays for Clostridium difficile infection: one or two gold standards?Timothy Planche, Mark Wilcox
Current Opinion in Infectious Diseases|October 27, 2016
New and emerging therapies for Clostridium difficile infectionJessica Martin, Mark Wilcox
The Journal of Antimicrobial Chemotherapy|July 27, 2012
Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter?Carolyne Horner, Damien Mawer, Mark Wilcox
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 26, 2022
Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view?Marcela Krutova, Mark Wilcox, Ed Kuijper
The Journal of Antimicrobial Chemotherapy|January 20, 2004
Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infectionsMark Wilcox, Dilip Nathwani, Matthew Dryden
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2015
Fecal-Free Toxin Detection Remains the Best Way to Detect Clostridium difficile InfectionTim Planche, Mark Wilcox, A Sarah Walker
Infection Control and Hospital Epidemiology|April 4, 2017
Is AGREE II a counsel of perfection? A letter commenting on Lytvyn et alSheldon P Stone, Mark Wilcox, Peter Hawkey
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Future Microbiology|August 6, 2016
Interview with Professor Mark WilcoxMark Wilcox
Annals of Internal Medicine|February 21, 2018
Increasing Incidence of Multiply Recurrent Clostridium difficile InfectionMark Wilcox
BMJ (Clinical Research Ed.)|February 14, 2013
Assuring the quality of diagnostic tests: how do we know that they do what we think they do?Mark Wilcox
Journal of Clinical Pathology|December 2, 2010
Reference assays for Clostridium difficile infection: one or two gold standards?Timothy Planche, Mark Wilcox
Current Opinion in Infectious Diseases|October 27, 2016
New and emerging therapies for Clostridium difficile infectionJessica Martin, Mark Wilcox
The Journal of Antimicrobial Chemotherapy|July 27, 2012
Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter?Carolyne Horner, Damien Mawer, Mark Wilcox
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 26, 2022
Clostridioides difficile infection: are the three currently used antibiotic treatment options equal from pharmacological and microbiological points of view?Marcela Krutova, Mark Wilcox, Ed Kuijper
The Journal of Antimicrobial Chemotherapy|January 20, 2004
Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infectionsMark Wilcox, Dilip Nathwani, Matthew Dryden
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 21, 2015
Fecal-Free Toxin Detection Remains the Best Way to Detect Clostridium difficile InfectionTim Planche, Mark Wilcox, A Sarah Walker
Infection Control and Hospital Epidemiology|April 4, 2017
Is AGREE II a counsel of perfection? A letter commenting on Lytvyn et alSheldon P Stone, Mark Wilcox, Peter Hawkey
Pageof 8